CytoSorbents Corp.

CytoSorbents Corp. is a therapeutic medical device company, which is engaged in the developing of products to support healthcare professionals in the treatment of complex medical conditions using blood purification to treat life threatening diseases. The company develops two products: CytoSorb and BetaSorb. The CytoSorb device consists of a cartridge containing hemocompatible, highly porous, adsorbent polymer beads that are intended remove toxins and other substances from blood and physiologic fluids. The BetaSorb device is intended to remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure who rely on long term dialysis therapy to sustain their life. The company was founded on April 25, 2002 and is headquartered in Monmouth Junction, NJ